Biogen Idec (BIIB) Receives TGA Approval for FAMPYRA

May 16, 2011 7:09 AM EDT Send to a Friend
Biogen Idec (Nasdaq: BIIB) reports that the Australian Therapeutic Goods Administration (TGA) has granted approval for FAMPYRA, (fampridine) 10 mg ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login